Novo Integrated Sciences, Inc. (NVOS)

NASDAQ: NVOS · IEX Real-Time Price · USD
0.119
-0.006 (-4.49%)
Feb 1, 2023, 10:06 AM EST - Market open
-4.49%
Market Cap 7.10M
Revenue (ttm) 22.58M
Net Income (ttm) -12.36M
Shares Out 59.64M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,467,353
Open 0.121
Previous Close 0.125
Day's Range 0.117 - 0.122
52-Week Range 0.101 - 3.320
Beta -0.15
Analysts n/a
Price Target n/a
Earnings Date Jan 31, 2023

About NVOS

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and base... [Read more]

Sector Healthcare
IPO Date Sep 22, 2017
Employees 73
Stock Exchange NASDAQ
Ticker Symbol NVOS
Full Company Profile

Financial Performance

In 2021, NVOS's revenue was $9.31 million, an increase of 18.38% compared to the previous year's $7.86 million. Losses were -$4.46 million, -9.22% less than in 2020.

Financial Statements

News

Novo Integrated Sciences Announces Receipt of Notice from Nasdaq

BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today reported that it received a notice on January 25, 2023 from the Listing Qualification...

1 day ago - Business Wire

Why Is Novo Integrated Sciences (NVOS) Stock Up 27% Today?

Novo Integrated Sciences (NASDAQ: NVOS) stock is taking off on Tuesday despite a lack of news concerning the healthcare company. Instead, investors have heavy trading to thank for the rise in price t...

1 week ago - InvestorPlace

5 Health Care Stocks That Are Diving - And May Rally

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: FATEIPSCSNPXTECH
1 week ago - Benzinga

Novo Integrated Sciences Provides Update on Certain Current Actions and Events

BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today provides an update with respect to certain actions and events, as follows:

2 weeks ago - Business Wire

Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.

BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International LLC (“CCI”), a Novo wholly-owned subsidiary, today a...

2 months ago - Business Wire

Embracing Technology and Innovation “Key” to Easing Healthcare Crisis

VAUGHAN, Ontario--(BUSINESS WIRE)---- $NVOS #HealthCanadaNPN--Embracing Technology and Innovation “Key” to Easing Healthcare Crisis. Greater Toronto Area Company Improving Healthcare Delivery and Trea...

6 months ago - Business Wire

Novo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third Quarter

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a...

7 months ago - Business Wire

Novo Integrated Sciences Announces Preliminary Revenue Range for Fiscal 2022 Third Quarter

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a...

7 months ago - Business Wire

Novo Integrated Sciences' Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and Beyond

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences' Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and Beyond

7 months ago - Business Wire

Novo Integrated Sciences' Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences' Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP

10 months ago - Business Wire

Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results.

10 months ago - Business Wire

Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC and Appoints Dr. Joseph Chalil as Chief Medical Officer

10 months ago - Business Wire

Novo Integrated Sciences Signs Memorandum of Understanding with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Signs MOU with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America

11 months ago - Business Wire

Novo Integrated Sciences' PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences' PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology

11 months ago - Business Wire

Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness throu...

11 months ago - Business Wire

Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest

11 months ago - Business Wire

Novo Integrated Sciences' IoNovo Iodide Granted Natural Product Number (NPN) by Health Canada

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences' IoNovo Iodide Granted Natural Product Number (NPN) by Health Canada

11 months ago - Business Wire

Novo Integrated Sciences' IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences' IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number by Health Canada Proven to be Safe and Effective.

1 year ago - Business Wire

Novo Integrated Sciences Reports First Quarter Financial Results

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Reports First Quarter Financial Results

1 year ago - Business Wire

Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Announces Signing of a Master Facility License Agreement with LA Fitness in Canada

1 year ago - Business Wire

Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product

BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product

1 year ago - Business Wire